HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Umemura, K. Articles by Matsuura, H. Search for Related Content PubMed PubMed Citation Articles by Umemura, K. Articles by Matsuura, H.

PET Study of the Neuroprotective Effect of TRA-418, an Antiplatelet Agent, in a Monkey Model of Stroke

¹ Department of Pharmacology, Hamamatsu University School of Medicine, Hamamatsu, Japan
² Central Research Laboratory, Hamamatsu Photonics K.K., Shizuoka, Japan
³ Pharmaceutical Research Laboratories, Toray Industries, Inc., Kanagawa, Japan

The aim of this study was to evaluate the neuroprotective effect of TRA-418, an antiplatelet agent, using PET in a monkey model of stroke. TRA-418 is a nonprostanoid compound with dual action: antagonistic effects on thromboxane A₂ receptors and agonistic effects on prostaglandin I₂ receptors. Methods: Via a transorbital approach, cynomolgus monkeys underwent a 3-h occlusion of the right middle cerebral artery (MCA), followed by reperfusion and observation for 4 d. Starting 2 h after the MCA occlusion, TRA-418 was administered at low and high doses (6 animals at each dose). Six control animals received a bolus and infusion of drug vehicle after MCA occlusion. Steady-state ¹⁵O continuous inhalation was used for assessment of local cerebral blood flow, cerebral metabolic rate of oxygen, and oxygen extraction fraction using high-resolution PET. Five consecutive PET scans (before occlusion; 2 h after occlusion; and 2 h, 24 h, and 4 d after reperfusion) were obtained for each monkey. The extent of the cerebral damage due to ischemia was measured histologically at 4 d after reperfusion. Results: Histologic observation 4 d after MCA occlusion showed that cerebral damage was less (P = 0.05) in animals treated with high-dose TRA-418 than in control animals. Although not affecting cerebral blood flow during the experiments, treatment with TRA-418 significantly (P < 0.05) suppressed reduction of the cerebral metabolic rate of oxygen after reperfusion. Conclusion: Our observations suggest that TRA-418 has neuroprotective action, as displayed in a primate model of stroke using PET monitoring.

Key Words: monkey stroke model • antiplatelet agency • PET

Related articles in JNM:

THIS MONTH IN JNM

JNM 2005 46: 7a-8a. [Full Text]  

This article has been cited by other articles:

				Y. Cui, H. Takamatsu, T. Kakiuchi, H. Ohba, Y. Kataoka, C. Yokoyama, H. Onoe, Y. Watanabe, T. Hosoya, M. Suzuki, et al. Neuroprotection by a Central Nervous System-Type Prostacyclin Receptor Ligand Demonstrated in Monkeys Subjected to Middle Cerebral Artery Occlusion and Reperfusion: A Positron Emission Tomography Study Stroke, November 1, 2006; 37(11): 2830 - 2836. [Abstract] [Full Text] [PDF]